# Azacitidine

NDC: 68001-313
Generic name: Azacitidine
Labeler / Manufacturer: BluePoint Laboratories
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20170701
Marketing ended: 20261231
FDA application: NDA208216

## Active ingredients

- AZACITIDINE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"68001-313"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=68001-313
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a